The global Extracorporeal Ventricular Assist Device market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Abiomed, Inc.
Thoratec
Medos Medizintechnik AG
Berlin Heart
Thoratec
Maquet Cardiovascular
Novacor
By Types:
Mechanics
Digital
By Applications:
Hospital
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Extracorporeal Ventricular Assist Device Market Size Analysis from 2023 to 2028
1.5.1 Global Extracorporeal Ventricular Assist Device Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Extracorporeal Ventricular Assist Device Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Extracorporeal Ventricular Assist Device Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Extracorporeal Ventricular Assist Device Industry Impact
Chapter 2 Global Extracorporeal Ventricular Assist Device Competition by Types, Applications, and Top Regions and Countries
2.1 Global Extracorporeal Ventricular Assist Device (Volume and Value) by Type
2.1.1 Global Extracorporeal Ventricular Assist Device Consumption and Market Share by Type (2017-2022)
2.1.2 Global Extracorporeal Ventricular Assist Device Revenue and Market Share by Type (2017-2022)
2.2 Global Extracorporeal Ventricular Assist Device (Volume and Value) by Application
2.2.1 Global Extracorporeal Ventricular Assist Device Consumption and Market Share by Application (2017-2022)
2.2.2 Global Extracorporeal Ventricular Assist Device Revenue and Market Share by Application (2017-2022)
2.3 Global Extracorporeal Ventricular Assist Device (Volume and Value) by Regions
2.3.1 Global Extracorporeal Ventricular Assist Device Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Extracorporeal Ventricular Assist Device Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Extracorporeal Ventricular Assist Device Consumption by Regions (2017-2022)
4.2 North America Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
4.10 South America Extracorporeal Ventricular Assist Device Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Extracorporeal Ventricular Assist Device Market Analysis
5.1 North America Extracorporeal Ventricular Assist Device Consumption and Value Analysis
5.1.1 North America Extracorporeal Ventricular Assist Device Market Under COVID-19
5.2 North America Extracorporeal Ventricular Assist Device Consumption Volume by Types
5.3 North America Extracorporeal Ventricular Assist Device Consumption Structure by Application
5.4 North America Extracorporeal Ventricular Assist Device Consumption by Top Countries
5.4.1 United States Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
5.4.2 Canada Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
5.4.3 Mexico Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 6 East Asia Extracorporeal Ventricular Assist Device Market Analysis
6.1 East Asia Extracorporeal Ventricular Assist Device Consumption and Value Analysis
6.1.1 East Asia Extracorporeal Ventricular Assist Device Market Under COVID-19
6.2 East Asia Extracorporeal Ventricular Assist Device Consumption Volume by Types
6.3 East Asia Extracorporeal Ventricular Assist Device Consumption Structure by Application
6.4 East Asia Extracorporeal Ventricular Assist Device Consumption by Top Countries
6.4.1 China Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
6.4.2 Japan Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
6.4.3 South Korea Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 7 Europe Extracorporeal Ventricular Assist Device Market Analysis
7.1 Europe Extracorporeal Ventricular Assist Device Consumption and Value Analysis
7.1.1 Europe Extracorporeal Ventricular Assist Device Market Under COVID-19
7.2 Europe Extracorporeal Ventricular Assist Device Consumption Volume by Types
7.3 Europe Extracorporeal Ventricular Assist Device Consumption Structure by Application
7.4 Europe Extracorporeal Ventricular Assist Device Consumption by Top Countries
7.4.1 Germany Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.2 UK Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.3 France Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.4 Italy Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.5 Russia Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.6 Spain Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.7 Netherlands Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.8 Switzerland Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
7.4.9 Poland Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 8 South Asia Extracorporeal Ventricular Assist Device Market Analysis
8.1 South Asia Extracorporeal Ventricular Assist Device Consumption and Value Analysis
8.1.1 South Asia Extracorporeal Ventricular Assist Device Market Under COVID-19
8.2 South Asia Extracorporeal Ventricular Assist Device Consumption Volume by Types
8.3 South Asia Extracorporeal Ventricular Assist Device Consumption Structure by Application
8.4 South Asia Extracorporeal Ventricular Assist Device Consumption by Top Countries
8.4.1 India Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
8.4.2 Pakistan Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Extracorporeal Ventricular Assist Device Market Analysis
9.1 Southeast Asia Extracorporeal Ventricular Assist Device Consumption and Value Analysis
9.1.1 Southeast Asia Extracorporeal Ventricular Assist Device Market Under COVID-19
9.2 Southeast Asia Extracorporeal Ventricular Assist Device Consumption Volume by Types
9.3 Southeast Asia Extracorporeal Ventricular Assist Device Consumption Structure by Application
9.4 Southeast Asia Extracorporeal Ventricular Assist Device Consumption by Top Countries
9.4.1 Indonesia Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
9.4.2 Thailand Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
9.4.3 Singapore Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
9.4.4 Malaysia Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
9.4.5 Philippines Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
9.4.6 Vietnam Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
9.4.7 Myanmar Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 10 Middle East Extracorporeal Ventricular Assist Device Market Analysis
10.1 Middle East Extracorporeal Ventricular Assist Device Consumption and Value Analysis
10.1.1 Middle East Extracorporeal Ventricular Assist Device Market Under COVID-19
10.2 Middle East Extracorporeal Ventricular Assist Device Consumption Volume by Types
10.3 Middle East Extracorporeal Ventricular Assist Device Consumption Structure by Application
10.4 Middle East Extracorporeal Ventricular Assist Device Consumption by Top Countries
10.4.1 Turkey Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.3 Iran Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.5 Israel Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.6 Iraq Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.7 Qatar Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.8 Kuwait Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
10.4.9 Oman Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 11 Africa Extracorporeal Ventricular Assist Device Market Analysis
11.1 Africa Extracorporeal Ventricular Assist Device Consumption and Value Analysis
11.1.1 Africa Extracorporeal Ventricular Assist Device Market Under COVID-19
11.2 Africa Extracorporeal Ventricular Assist Device Consumption Volume by Types
11.3 Africa Extracorporeal Ventricular Assist Device Consumption Structure by Application
11.4 Africa Extracorporeal Ventricular Assist Device Consumption by Top Countries
11.4.1 Nigeria Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
11.4.2 South Africa Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
11.4.3 Egypt Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
11.4.4 Algeria Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
11.4.5 Morocco Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 12 Oceania Extracorporeal Ventricular Assist Device Market Analysis
12.1 Oceania Extracorporeal Ventricular Assist Device Consumption and Value Analysis
12.2 Oceania Extracorporeal Ventricular Assist Device Consumption Volume by Types
12.3 Oceania Extracorporeal Ventricular Assist Device Consumption Structure by Application
12.4 Oceania Extracorporeal Ventricular Assist Device Consumption by Top Countries
12.4.1 Australia Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
12.4.2 New Zealand Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 13 South America Extracorporeal Ventricular Assist Device Market Analysis
13.1 South America Extracorporeal Ventricular Assist Device Consumption and Value Analysis
13.1.1 South America Extracorporeal Ventricular Assist Device Market Under COVID-19
13.2 South America Extracorporeal Ventricular Assist Device Consumption Volume by Types
13.3 South America Extracorporeal Ventricular Assist Device Consumption Structure by Application
13.4 South America Extracorporeal Ventricular Assist Device Consumption Volume by Major Countries
13.4.1 Brazil Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
13.4.2 Argentina Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
13.4.3 Columbia Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
13.4.4 Chile Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
13.4.5 Venezuela Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
13.4.6 Peru Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
13.4.8 Ecuador Extracorporeal Ventricular Assist Device Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Extracorporeal Ventricular Assist Device Business
14.1 Abiomed, Inc.
14.1.1 Abiomed, Inc. Company Profile
14.1.2 Abiomed, Inc. Extracorporeal Ventricular Assist Device Product Specification
14.1.3 Abiomed, Inc. Extracorporeal Ventricular Assist Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Thoratec
14.2.1 Thoratec Company Profile
14.2.2 Thoratec Extracorporeal Ventricular Assist Device Product Specification
14.2.3 Thoratec Extracorporeal Ventricular Assist Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Medos Medizintechnik AG
14.3.1 Medos Medizintechnik AG Company Profile
14.3.2 Medos Medizintechnik AG Extracorporeal Ventricular Assist Device Product Specification
14.3.3 Medos Medizintechnik AG Extracorporeal Ventricular Assist Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Berlin Heart
14.4.1 Berlin Heart Company Profile
14.4.2 Berlin Heart Extracorporeal Ventricular Assist Device Product Specification
14.4.3 Berlin Heart Extracorporeal Ventricular Assist Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Thoratec
14.5.1 Thoratec Company Profile
14.5.2 Thoratec Extracorporeal Ventricular Assist Device Product Specification
14.5.3 Thoratec Extracorporeal Ventricular Assist Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Maquet Cardiovascular
14.6.1 Maquet Cardiovascular Company Profile
14.6.2 Maquet Cardiovascular Extracorporeal Ventricular Assist Device Product Specification
14.6.3 Maquet Cardiovascular Extracorporeal Ventricular Assist Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Novacor
14.7.1 Novacor Company Profile
14.7.2 Novacor Extracorporeal Ventricular Assist Device Product Specification
14.7.3 Novacor Extracorporeal Ventricular Assist Device Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Extracorporeal Ventricular Assist Device Market Forecast (2023-2028)
15.1 Global Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Extracorporeal Ventricular Assist Device Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Extracorporeal Ventricular Assist Device Value and Growth Rate Forecast (2023-2028)
15.2 Global Extracorporeal Ventricular Assist Device Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Extracorporeal Ventricular Assist Device Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Extracorporeal Ventricular Assist Device Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Extracorporeal Ventricular Assist Device Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Extracorporeal Ventricular Assist Device Consumption Forecast by Type (2023-2028)
15.3.2 Global Extracorporeal Ventricular Assist Device Revenue Forecast by Type (2023-2028)
15.3.3 Global Extracorporeal Ventricular Assist Device Price Forecast by Type (2023-2028)
15.4 Global Extracorporeal Ventricular Assist Device Consumption Volume Forecast by Application (2023-2028)
15.5 Extracorporeal Ventricular Assist Device Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
| Price : US$ 3500 |
Date : Dec 2025 |
| Category : Telecom and IT |
Pages : 212 |
| Price : US$ 3500 |
Date : Dec 2025 |
| Category : Electronics |
Pages : 199 |
| Price : US$ 3500 |
Date : Dec 2025 |
| Category : Telecom and IT |
Pages : 213 |
| Price : US$ 3500 |
Date : Dec 2025 |
| Category : Telecom and IT |
Pages : 182 |
Request Sample 
Request Discount 
Inquire Before Buy
